Old Web
English
Sign In
Acemap
>
authorDetail
>
Naval Daver
Naval Daver
University of Texas Health Science Center at Houston
Medicine
Pomalidomide
Immunology
Bone marrow
Lenalidomide
3
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
AML-320: PD-1 Inhibition Facilitates the Anti-AML Response of Co-Targeting BCL-2 and Methyltransferases through Modulation of the Immune Microenvironment
2020
Clinical Lymphoma, Myeloma & Leukemia
Zhihong Zeng
Shelley Herbrich
Tianyu Cai
Antonio Cavazos
Taylor Manzella
Jairo Matthews
Courtney Dinardo
Naval Daver
Marina Konopleva
Show All
Source
Cite
Save
Citations (0)
Pegilodecakin Combined with Anti-PD-1 Monoclonal Antibodies for Patients with Advanced Renal Cell Carcinoma (IVY): A Multicentre, Open-Label, Phase 1b Trial
2019
Social Science Research Network
A. Naing
Jeffrey R. Infante
Deborah J. Wong
Michael Korn
R. Aljumaily
Kyriakos P. Papadopoulos
Karen A. Autio
S. Pant
Todd M. Bauer
Alexandra Drakaki
Naval Daver
Annie Hung
Navneet Ratti
Scott Alan Mccauley
Peter Van Vlasselaer
Rakesh Verma
David Ferry
Martin Oft
Nizar M. Tannir
Show All
Source
Cite
Save
Citations (0)
Immunotherapy based approaches in myelofibrosis
2017
Expert Review of Hematology
Lucia Masarova
Srdan Verstovsek
H. Kantarjian
Naval Daver
Show All
Source
Cite
Save
Citations (8)
1